Target intelligence / Profile preview

Host Gut Microbiota and Environment

Molecular classification
Other
01

Overview

The host gut microbiota and environment encompass the vast community of bacteria, viruses, fungi, and archaea inhabiting the gastrointestinal tract, along with the local physiological conditions such as pH and mucus layers. This complex ecosystem functions as a metabolic organ, contributing to the breakdown of complex carbohydrates, the synthesis of vitamins (e.g., K and B12), and the maturation of the host immune system (NIH, 2023). It plays a pivotal role in maintaining the intestinal barrier and preventing the colonization of pathogenic organisms. Disruptions to this balance, termed dysbiosis, are implicated in a wide range of pathologies, including inflammatory bowel disease, metabolic syndrome, and neuropsychiatric disorders (Nature Reviews Microbiology, 2021). Therapeutic strategies targeting this system include the use of probiotics, prebiotics, and fecal microbiota transplantation to restore healthy microbial diversity. Additionally, common drugs like metformin have been shown to exert part of their therapeutic effect by altering the gut microbial composition (Nature Medicine, 2017). The environment also influences drug metabolism and bioavailability, making it a critical factor in personalized medicine.

Other names
Gut microbiomeIntestinal floraGastrointestinal microbiotaCommensal microbiotaGut-lung axisGut-brain axis
02

Mechanism of action

Modulation of microbial composition and diversity, production of metabolites such as short-chain fatty acids (SCFAs), and restoration of homeostatic balance (eubiosis) from a state of dysbiosis.

03

Biological functions

MetabolismImmune responseNutrient absorptionProtection against pathogensSynthesis of vitaminsMaintenance of intestinal barrier
04

Disease associations

Inflammatory bowel diseaseObesityType 2 diabetesColorectal cancerNeurodegenerative diseaseCardiovascular diseaseInfection
05

Safety considerations

Risk of dysbiosisAntibiotic resistanceSystemic translocation of bacteriaLack of standardization in microbial therapiesPotential for opportunistic infections
06

Interacting drugs

Vancomycin

6 more in the full profile.

07

Biomarkers

Microbial diversity indexFirmicutes/Bacteroidetes ratioShort-chain fatty acid levelsFecal calprotectinAkkermansia muciniphila abundance

Beyond the preview

Go deeper on Host Gut Microbiota and Environment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host Gut Microbiota and Environment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call